Prevalence and Determinants of COVID-19 Vaccine Hesitancy Among the Ethiopian Population: A Systematic Review.

COVID-19 Ethiopia acceptance hesitancy systematic review vaccine

Journal

Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264

Informations de publication

Date de publication:
2022
Historique:
received: 26 03 2022
accepted: 25 07 2022
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 9 8 2022
Statut: epublish

Résumé

Although vaccination is the most effective way to end the COVID-19 pandemic, there are growing concerns that vaccine hesitancy may undermine its effectiveness. In Ethiopia, vaccine hesitancy forms a major challenge to the uptake of COVID-19 vaccines. This systematic review examined the prevalence and determinants of the COVID-19 vaccine hesitancy among the Ethiopian population. A systematic search of articles was conducted in PubMed, EBSCO, Google Scholar, and Semantic Scholar. Studies that evaluated the prevalence and determinants of COVID-19 vaccine hesitancy in Ethiopia were included. The identified determinants of COVID-19 vaccine hesitancy were analyzed based on the frequency of occurrence in the included studies. The overall COVID-19 vaccine hesitancy level in the Ethiopian population ranged from 14.1% to 68.7%. The high COVID-19 vaccine hesitancy rate observed in this study was due to contextual factors, individual factors, and vaccine-specific factors. Young age, female sex, living in rural areas, lack of adequate information, and lower education are the most common contextual determinants of the COVID-19 vaccine hesitancy. Lack of awareness about the COVID-19 vaccine, low risk of COVID-19, poor adherence to COVID-19 prevention strategies, and negative attitude towards the COVID-19 vaccine are the most frequently reported personal factors. Common vaccine-specific determinants of COVID-19 vaccine hesitation are the side effects of the vaccine and doubts about its effectiveness of the vaccine. Our review showed that COVID-19 vaccine hesitancy remains highly prevalent and varied across regions of Ethiopia, with a wide variety of factors associated with it. Potential interventions on the benefits of vaccination and the adverse effects of vaccine rejection are crucial to enhance COVID-19 vaccine uptake among the Ethiopian population.

Identifiants

pubmed: 35937966
doi: 10.2147/RMHP.S368057
pii: 368057
pmc: PMC9346414
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1433-1445

Informations de copyright

© 2022 Yehualashet et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest in this work.

Références

Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Epidemiol Infect. 2021 May 11;149:e123
pubmed: 33972001
Vaccines (Basel). 2021 Dec 07;9(12):
pubmed: 34960192
Public Health. 2021 Sep;198:252-259
pubmed: 34492505
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Prev Med Rep. 2021 Dec 16;25:101673
pubmed: 34934611
PLoS One. 2021 Dec 17;16(12):e0261125
pubmed: 34919597
J Multidiscip Healthc. 2021 May 28;14:1233-1243
pubmed: 34093019
Euro Surveill. 2021 Apr;26(17):
pubmed: 33928899
Infect Drug Resist. 2021 Dec 19;14:5531-5541
pubmed: 34984008
Vaccines (Basel). 2021 Aug 13;9(8):
pubmed: 34452026
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Risk Manag Healthc Policy. 2021 Jun 28;14:2743-2756
pubmed: 34234590
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
PLoS One. 2021 Mar 24;16(3):e0248892
pubmed: 33760836
Infect Drug Resist. 2021 Jun 01;14:2015-2025
pubmed: 34103948
Vaccine. 2015 Aug 14;33(34):4180-90
pubmed: 25896377
R Soc Open Sci. 2020 Oct 14;7(10):201199
pubmed: 33204475
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
J Perinat Med. 2021 Apr 28;49(6):678-685
pubmed: 33905622
PLoS One. 2021 Apr 27;16(4):e0250495
pubmed: 33905442
BMJ. 2020 Nov 30;371:m4654
pubmed: 33257346
Patient Prefer Adherence. 2021 Aug 17;15:1795-1805
pubmed: 34429591
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Am J Prev Med. 2020 Oct;59(4):493-503
pubmed: 32778354
Am J Infect Control. 2021 Oct;49(10):1295-1304
pubmed: 34273461
PLoS One. 2021 Feb 8;16(2):e0246772
pubmed: 33556142
J Community Health. 2021 Dec;46(6):1244-1251
pubmed: 33877534
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
PLoS One. 2020 Dec 3;15(12):e0243264
pubmed: 33270783
J Glob Health. 2021 Nov 20;11:05027
pubmed: 34912550
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211013303
pubmed: 33913365
PLoS One. 2021 Jul 12;16(7):e0254391
pubmed: 34252143
Infect Drug Resist. 2021 Oct 14;14:4249-4259
pubmed: 34703251
Front Med (Lausanne). 2021 Mar 01;8:644300
pubmed: 33732723
Vaccines (Basel). 2021 May 02;9(5):
pubmed: 34063313
Epidemiol Infect. 2021 Oct 14;149:e225
pubmed: 34645533
Infect Drug Resist. 2021 Jun 24;14:2361-2367
pubmed: 34194232
Vaccines (Basel). 2021 Jan 14;9(1):
pubmed: 33466675
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
PLoS One. 2021 Jun 24;16(6):e0253499
pubmed: 34166399
SAGE Open Med. 2021 Aug 19;9:20503121211038454
pubmed: 34434555
PLoS One. 2021 Sep 3;16(9):e0257109
pubmed: 34478470
Front Public Health. 2021 Apr 21;9:626852
pubmed: 33968880
Front Public Health. 2021 Oct 08;9:739003
pubmed: 34692626
Int J Environ Res Public Health. 2021 Mar 08;18(5):
pubmed: 33800187
Postgrad Med J. 2022 Oct 1;98(1164):756-764
pubmed: 37062994
BMC Public Health. 2022 Jan 18;22(1):128
pubmed: 35042476
Pragmat Obs Res. 2021 May 27;12:37-47
pubmed: 34079423
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
Diabetes Metab Syndr. 2021 May-Jun;15(3):987-992
pubmed: 33984818
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Int J Emerg Med. 2020 Jul 20;13(1):40
pubmed: 32689925
Radiology. 2020 Apr;295(1):210-217
pubmed: 32027573
Infect Drug Resist. 2021 Aug 11;14:3071-3082
pubmed: 34408451
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Eur J Epidemiol. 2020 Aug;35(8):785-788
pubmed: 32808095
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100848
pubmed: 34395948
EClinicalMedicine. 2021 Oct;40:101113
pubmed: 34490416
Infect Drug Resist. 2021 Nov 23;14:4865-4876
pubmed: 34848979
Virusdisease. 2021 Jun;32(2):272-278
pubmed: 34222565
Front Public Health. 2021 Nov 23;9:770985
pubmed: 34888288
Lancet Infect Dis. 2021 Mar;21(3):318-319
pubmed: 32619436
Patient Prefer Adherence. 2021 Dec 09;15:2731-2738
pubmed: 34916783
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713

Auteurs

Delelegn Emwodew Yehualashet (DE)

School of Public Health, Dilla University, Dilla, Ethiopia.

Binyam Tariku Seboka (BT)

School of Public Health, Dilla University, Dilla, Ethiopia.

Getanew Aschalew Tesfa (GA)

School of Public Health, Dilla University, Dilla, Ethiopia.

Tizalegn Tesfaye Mamo (TT)

School of Public Health, Dilla University, Dilla, Ethiopia.

Mulugeta Namaro Yawo (MN)

School of Public Health, Dilla University, Dilla, Ethiopia.

Samuel Hailegebreal (S)

School of Public Health, Arba Minch University, Arba Minch, Ethiopia.

Classifications MeSH